PRESS RELEASE: TGV-Dx Announces Study Results Showing AtbFinder as Novel Paradigm for Rapid Antibiotic Susceptibility Testing for Multidrug-Resistant Infections
TGV-Dx, Inc, a development-stage in vitro diagnostics company developing advanced systems that impro…